Daojin Yang
Chairman and CEO
Replay available
Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call
Ascentage Pharma Group International (NASDAQ: AAPG) Q4 2025 earnings conference call, held 2026-03-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Yuli Shen
Senior Director of Investor Relations
Brian Cheng
Analyst, J.P. Morgan
Qu Chao Si
Head of Commercial
Jeet Mukherjee
Analyst, BTIG
Dr. Veet Misra
Chief Financial Officer
Byron Amin
Analyst, Piper Sandler
Christopher Leao
Analyst, Lucid Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ascentage Pharma Group International.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.459 Good day, everyone, and welcome to Ascentage Farmers 2025 Annual 00:00:05.459 -- 00:00:10.926 Results Earnings Call. At this time, all participants are in a listen-only 00:00:10.926 -- 00:00:12.389 mode. 00:00:12.389 -- 00:00:17.316 After management's prepared remarks, we will open the call for questions. 00:00:17.316 -- 00:00:20.240 As a reminder, today's call is being recorded. 00:00:20.240 -- 00:00:25.407 Thank you for joining us. I will now turn the call over to Yuli Shen, 00:00:25.407 -- 00:00:30.654 Senior Director of Investor Relations for the Safe Harbour Statement Yuli, 00:00:30.654 -- 00:00:32.235 please go ahead. 00:00:32.235 -- 00:00:37.781 Thank you, operator. Please note that today's discussion will include forward-looking 00:00:37.781 -- 00:00:42.485 statements based on our current expectations and assumptions. 00:00:42.485 -- 00:00:47.911 These statements involve risks and uncertainties, and actual results 00:00:47.911 -- 00:00:53.216 may differ materially. For full discussion of these risks, please refer 00:00:53.216 -- 00:00:58.308 to our filings and disclosures. On today's call, I am joined by 00:00:58.308 -- 00:01:03.373 Dr. Da Junyang, Chairman and CEO, who will provide an overview 00:01:03.373 -- 00:01:08.619 of recent developments and 2025 annual performance, as well as Dr. 00:01:08.619 -- 00:01:13.345 Veet Misra, CFO, who will go through the financial highlights. 00:01:13.345 -- 00:01:17.269 The presentation will then be followed by a Q&A session. 00:01:17.269 -- 00:01:21.734 During this Q&A session, the team will be joined by Dr. 00:01:21.734 -- 00:01:27.289 Yifan Zhai, Chief Medical Officer, Dr. Xiaomeng Wang, co-founder, chief scientific 00:01:27.289 -- 00:01:31.114 advisor. Dr. Qu Chao Si, head of commer...